Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-022232
Filing Date
2022-06-02
Accepted
2022-06-02 16:06:16
Documents
5
Effectiveness Date
2022-06-02

Document Format Files

Seq Description Document Type Size
1 S-8 dvax-s8.htm S-8 157530
2 EX-5.1 dvax-ex51_41.htm EX-5.1 11282
3 EX-23.1 dvax-ex231_15.htm EX-23.1 2986
4 EX-FILING FEES dvax-exfilingfees_87.htm EX-FILING FEES 31110
5 GRAPHIC gthgv4dymrf4000001.jpg GRAPHIC 33494
  Complete submission text file 0001564590-22-022232.txt   250208
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265373 | Film No.: 22990812
SIC: 2834 Pharmaceutical Preparations